20746-64-9

Basic information

• Product Name: Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside
• Synonyms: Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside;Allyl 4,6-O-benzylidene-a-D-galactopyranoside;Allyl4,6-O-benzylidene-a-D-glucopyranoside;Allyl-4,6-O-benzylidene-α-D-glucopyranoside;Allyl 4,6-O-benzylidene-α-D-galactopyranoside;2-Propenyl 4,6-O-(phenylmethylene)-alpha-D-galactopyranoside;a-D-Galactopyranoside,2-propenyl 4,6-O-(phenylmethylene)- (9CI)
• CAS NO: 20746-64-9
• Molecular Formula: C₁₆H₂₀O₆
• Molecular Weight: 308.3264
• EINECS: 1533716-785-6
• Mol File: 20746-64-9.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside(20746-64-9)
• EPA Substance Registry System: Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside(20746-64-9)

Safety Data

• Hazardous Substances Data: 20746-64-9(Hazardous Substances Data)

Usage

General Description

Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside is a chemical compound with the molecular formula C17H20O6. It is a derivative of glucose and belongs to the class of glycosides. Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside is commonly used in organic synthesis and as a reagent in chemical reactions. It is also known for its potential use in the development of pharmaceuticals and other bioactive compounds. Allyl 4,6-O-benzylidene-alpha-D-glucopyranoside has been studied for its various biological activities, including antiviral, anticancer, and anti-inflammatory properties, making it a potentially valuable compound for medicinal and pharmaceutical applications.

Upstream product

• 1125-88-8 benzaldehyde dimethyl acetal 
• 48149-74-2 allyl D-glucopyranoside 
• 492-61-5 β-D-glucose 
• 59-23-4 D-Galactose 
• 107-18-6 allyl alcohol 
• 100-52-7 benzaldehyde 
• 48149-72-0 (2S,3R,4S,5R,6R)-2-Allyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 
• 572-09-8 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
• 10343-15-4 allyl 2,3,4,6-tetra-O-acetyl-D-galactopyranoside 
• 25878-60-8 D-galactose pentaacetate 
• 2280-44-6 D-Glucose 
• 3006-41-5 4,6-O-benzylidene-α,β-D-galactopyranose 
• 106-95-6 allyl bromide 
• 2595-07-5 allyl D-galactopyranoside 

Downstream Products

• 81713-13-5 allyl 4,6-O-benzylidene-2,3-di-O-(2-butenyl)-α-D-galactopyranoside 
• 137172-47-5 allyl 3-O-benzyl-(R)-4,6-O-benzylidene-β-D-glucopyranoside 
• 161277-33-4 allyl 2-O-benzyl-(R)-4,6-O-benzylidene-β-D-gluco-pyranoside 
• 145773-08-6 allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside 
• 760178-19-6 1-O-allyl-2,3-di-O-benzyl-6-O-tosyl-β-D-glucose 
• 760178-20-9 1-O-allyl-2,3-di-O-benzyl-4-O-(carbobenzoxy-β-alanyl)-6-O-tosyl-β-D-glucopyranoside 
• 760178-21-0 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-6-allyloxy-4,5-bis-benzyloxy-tetrahydro-pyran-3-yl ester 
• 760178-22-1 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-4,5-bis-benzyloxy-6-(2,3-dihydroxy-propoxy)-tetrahydro-pyran-3-yl ester 
• 1234307-27-7 C₅₄H₇₇NO₁₂S 
• 760178-23-2 Octadecanoic acid 2-[(2R,3R,4S,5S,6S)-6-acetylsulfanylmethyl-3,4-bis-benzyloxy-5-(3-benzyloxycarbonylamino-propionyloxy)-tetrahydro-pyran-2-yloxy]-1-octadecanoyloxymethyl-ethyl ester 
• 99541-24-9 O-(2,3-di-O-benzyl-β-D-glucopyranosyl)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 99541-26-1 O-(methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 

Relevant articles and documents

Preparation method of fondaparinux sodium disaccharide intermediate

The invention discloses a preparation method of fondaparinux sodium disaccharide intermediate. 1-O-substituent sulfonyl-2,3-bis-O-benzyl-4,6-O-benzylidene-beta-D-glucopyranose directly reacts with 1,6-dehydrated-2-deoxy-2-azido-3-O-acetyl-beta-D-glucopyranose to prepare the fondaparinux sodium disaccharide intermediate as shown in a formula I; and meanwhile, the fondaparinux sodium intermediate asshown in the formula I can be used as a raw material to synthesize fondaparinux sodium intermediate as shown in a formula IV. The preparation method is simple and small in steps, the yield is high, the atomic utilization rate is high, the three wastes are small, and the preparation method is suitable for industrial large-scale production. Please see the description for the formula.

5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors

(2S,3R,4R,5S,6R)-2-Aryl-5,5-difluoro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diols and (2S,3R,4R,5S,6R)-2-aryl-5-fluoro-5-methyl-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diols were discovered as dual inhibitors of sodium glucose co-transporter proteins (

BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS

The present invention is directed to benzocyclobutane derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by SGLT activity, more particularly dual SGLT1/2 activity. More particularly, the compounds of the present invention are useful in the treatment of for example, Type II diabetes mellitus, Syndrome X, and complications and symptoms associated with said disorders.